Monte Rosa Therapeutics Inc
NASDAQ: GLUE · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-11-20
Monte Rosa Therapeutics Inc (GLUE) Insider transactions
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-05 | BOWEN, MATTHEW | Principal Accounting Officer | S | 13 | $10.56 | $137.28 |
| 2026-07-16 | WARMUTH, MARKUS | Director, President & CEO | Sale | 9,500 | $23.18 | $220218.55 |
| 2026-07-15 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 4,351 | — | — |
| 2026-07-15 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 4,351 | $23.38 | $101729.86 |
| 2026-07-06 | TOWNSON, SHARON | Chief Scientific Officer | Sale | 6,000 | — | — |
| 2026-07-06 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 6,000 | $6.14 | $36840.00 |
| 2026-07-06 | TOWNSON, SHARON | Chief Scientific Officer | Sale | 5,600 | $23.25 | $130197.20 |
| 2026-07-06 | TOWNSON, SHARON | Chief Scientific Officer | Sale | 400 | $24.13 | $9652.00 |
| 2026-07-01 | BEHBAHANI, ALI | Director | Sale | 1,000,000 | — | — |
| 2026-07-01 | BEHBAHANI, ALI | Director | Buy | 15,000 | — | — |
| 2026-06-30 | JANKU, FILIP | Chief Medical Officer | Sale | 5,407 | — | — |
| 2026-06-30 | JANKU, FILIP | Chief Medical Officer | Buy | 5,407 | $13.41 | $72507.87 |
| 2026-06-29 | MANNING, ANTHONY M. | Director | Sale | 10,000 | — | — |
| 2026-06-29 | MANNING, ANTHONY M. | Director | Sale | 10,000 | $23.11 | $231100.00 |
| 2026-06-29 | JANKU, FILIP | Chief Medical Officer | Sale | 6,000 | — | — |
| 2026-06-29 | JANKU, FILIP | Chief Medical Officer | Sale | 6,000 | $22.95 | $137700.00 |
| 2026-06-24 | JANKU, FILIP | Chief Medical Officer | Sale | 30,000 | — | — |
| 2026-06-24 | JANKU, FILIP | Chief Medical Officer | Sale | 30,000 | $21.42 | $642681.00 |
| 2026-06-23 | TOWNSON, SHARON | Chief Scientific Officer | Sale | 3,000 | — | — |
| 2026-06-23 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 3,000 | $6.14 | $18420.00 |
| 2026-06-23 | JANKU, FILIP | Chief Medical Officer | Sale | 6,000 | — | — |
| 2026-06-23 | JANKU, FILIP | Chief Medical Officer | Sale | 11,845 | $20.22 | $239522.48 |
| 2026-06-23 | JANKU, FILIP | Chief Medical Officer | Buy | 6,000 | $7.56 | $45360.00 |
| 2026-06-23 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 2,175 | — | — |
| 2026-06-23 | CHAMPOUX, JENNIFER | Chief Operating Officer | Buy | 2,175 | $3.98 | $8656.50 |
| 2026-06-17 | TOWNSON, SHARON | Chief Scientific Officer | Sale | 3,000 | — | — |
| 2026-06-17 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 3,000 | $6.14 | $18420.00 |
| 2026-06-17 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 2,176 | — | — |
| 2026-06-17 | CHAMPOUX, JENNIFER | Chief Operating Officer | Buy | 2,176 | $3.98 | $8660.48 |
| 2026-06-11 | SKVARKA, JAN | Director | Buy | 25,800 | — | — |
| 2026-06-11 | SIU, CHRISTINE | Director | Buy | 25,800 | — | — |
| 2026-06-11 | SCHIFF, ANDREW N | Director | Buy | 25,800 | — | — |
| 2026-06-11 | MANNING, ANTHONY M. | Director | Buy | 25,800 | — | — |
| 2026-06-11 | HUGHES, ERIC A | Director | Buy | 25,800 | — | — |
| 2026-06-11 | BLACKWELL, KIMBERLY | Director | Buy | 25,800 | — | — |
| 2026-06-11 | BEHBAHANI, ALI | Director | Buy | 25,800 | — | — |
| 2026-06-01 | WARMUTH, MARKUS | Director, President & CEO | Sale | 4,998 | $19.41 | $97021.18 |
| 2026-06-01 | WARMUTH, MARKUS | Director, President & CEO | Sale | 468 | $19.73 | $9231.86 |
| 2026-05-29 | TOWNSON, SHARON | Chief Scientific Officer | Sale | 6,000 | — | — |
| 2026-05-29 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 6,000 | $6.14 | $36840.00 |
| 2026-05-27 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 2,175 | — | — |
| 2026-05-27 | CHAMPOUX, JENNIFER | Chief Operating Officer | Buy | 2,175 | $3.98 | $8656.50 |
| 2026-05-22 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 2,176 | — | — |
| 2026-05-22 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 2,176 | $19.00 | $41344.00 |
| 2026-05-21 | MANNING, ANTHONY M. | Director | Sale | 10,000 | — | — |
| 2026-05-21 | MANNING, ANTHONY M. | Director | Buy | 10,000 | $4.16 | $41600.00 |
| 2026-05-01 | WARMUTH, MARKUS | Director, President & CEO | Sale | 5,467 | $18.92 | $103446.57 |
| 2026-04-14 | WARMUTH, MARKUS | Director, President & CEO | Sale | 8,000 | $17.64 | $141124.80 |
| 2026-04-09 | NICKSON, PHILIP | Chief Business & Legal Officer | Sale | 5,845 | $17.69 | $103412.66 |
| 2026-04-06 | BOWEN, MATTHEW | Principal Accounting Officer | Buy | 19,500 | — | — |
| 2026-04-06 | BOWEN, MATTHEW | Principal Accounting Officer | Buy | 4,300 | — | — |
| 2026-03-04 | DUNN, EDMUND | Principal Accounting Officer | Sale | 139 | $17.96 | $2496.44 |
| 2026-03-02 | WARMUTH, MARKUS | Director, President & CEO | Sale | 5,466 | $17.92 | $97974.22 |
| 2026-03-02 | DUNN, EDMUND | Principal Accounting Officer | Sale | 536 | — | — |
| 2026-03-02 | DUNN, EDMUND | Principal Accounting Officer | Sale | 536 | $17.50 | $9380.00 |
| 2026-02-27 | DUNN, EDMUND | Principal Accounting Officer | Sale | 25,164 | — | — |
| 2026-02-27 | DUNN, EDMUND | Principal Accounting Officer | Buy | 25,164 | $13.41 | $337449.24 |
| 2026-02-23 | JANKU, FILIP | Chief Medical Officer | Sale | 9,189 | $19.50 | $179160.69 |
| 2026-01-07 | WARMUTH, MARKUS | Director, President & CEO | Sale | 3,707 | $23.24 | $86158.84 |
| 2026-01-07 | WARMUTH, MARKUS | Director, President & CEO | Sale | 1,450 | $23.88 | $34620.49 |
| 2026-01-07 | WARMUTH, MARKUS | Director, President & CEO | Sale | 309 | $24.57 | $7593.24 |
| 2026-01-05 | WARMUTH, MARKUS | Director, President & CEO | Sale | 10,135 | $15.17 | $153747.95 |
| 2026-01-05 | TOWNSON, SHARON | Chief Scientific Officer | Sale | 3,155 | $15.17 | $47861.35 |
| 2026-01-05 | NICKSON, PHILIP | Chief Business & Legal Officer | Sale | 3,155 | $15.17 | $47861.35 |
| 2026-01-05 | JANKU, FILIP | Chief Medical Officer | Sale | 3,155 | $15.17 | $47861.35 |
| 2026-01-05 | DUNN, EDMUND | Principal Accounting Officer | Sale | 1,039 | $15.17 | $15761.63 |
| 2026-01-05 | CHAMPOUX, JENNIFER | Chief Operating Officer | Sale | 2,629 | $15.17 | $39881.93 |
| 2026-01-02 | WARMUTH, MARKUS | Director, President & CEO | Buy | 406,000 | — | — |
| 2026-01-02 | WARMUTH, MARKUS | Director, President & CEO | Buy | 90,000 | — | — |
| 2026-01-02 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 158,000 | — | — |
| 2026-01-02 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 35,000 | — | — |
| 2026-01-02 | NICKSON, PHILIP | Chief Business & Legal Officer | Buy | 126,000 | — | — |
| 2026-01-02 | NICKSON, PHILIP | Chief Business & Legal Officer | Buy | 28,000 | — | — |
| 2026-01-02 | JANKU, FILIP | Chief Medical Officer | Buy | 139,000 | — | — |
| 2026-01-02 | JANKU, FILIP | Chief Medical Officer | Buy | 31,000 | — | — |
| 2026-01-02 | CHAMPOUX, JENNIFER | Chief Operating Officer | Buy | 158,000 | — | — |
| 2026-01-02 | CHAMPOUX, JENNIFER | Chief Operating Officer | Buy | 35,000 | — | — |
| 2025-06-13 | SKVARKA, JAN | Director | Buy | 30,700 | — | — |
| 2025-06-13 | SIU, CHRISTINE | Director | Buy | 30,700 | — | — |
| 2025-06-13 | SCHIFF, ANDREW N | Director | Buy | 30,700 | — | — |
| 2025-06-13 | MANNING, ANTHONY M. | Director | Buy | 30,700 | — | — |
| 2025-06-13 | HUGHES, ERIC A | Director | Buy | 30,700 | — | — |
| 2025-06-13 | BLACKWELL, KIMBERLY | Director | Buy | 30,700 | — | — |
| 2025-06-13 | BEHBAHANI, ALI | Director, 10% Owner | Buy | 30,700 | — | — |
| 2025-06-03 | DUNN, EDMUND | Principal Accounting Officer | Sale | 2,062 | $4.45 | $9174.46 |
| 2025-03-24 | LEO, CHANDRA P. | Director | Buy | 10,000 | $5.84 | $58383.00 |
| 2025-01-02 | WARMUTH, MARKUS | Director, President & CEO | Buy | 575,000 | — | — |
| 2025-01-02 | WARMUTH, MARKUS | Director, President & CEO | Buy | 128,000 | — | — |
| 2025-01-02 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 161,000 | — | — |
| 2025-01-02 | TOWNSON, SHARON | Chief Scientific Officer | Buy | 36,000 | — | — |
| 2025-01-02 | NICKSON, PHILIP | Chief Business & Legal Officer | Buy | 161,000 | — | — |
| 2025-01-02 | NICKSON, PHILIP | Chief Business & Legal Officer | Buy | 36,000 | — | — |
| 2025-01-02 | JANKU, FILIP | Chief Medical Officer | Buy | 161,000 | — | — |
| 2025-01-02 | JANKU, FILIP | Chief Medical Officer | Buy | 36,000 | — | — |
| 2025-01-02 | DUNN, EDMUND | Principal Accounting Officer | Buy | 53,400 | — | — |
| 2025-01-02 | DUNN, EDMUND | Principal Accounting Officer | Buy | 11,850 | — | — |
| 2025-01-02 | CHAMPOUX, JENNIFER | Chief Operating Officer | Buy | 135,000 | — | — |
| 2025-01-02 | CHAMPOUX, JENNIFER | Chief Operating Officer | Buy | 30,000 | — | — |
| 2024-12-11 | HUGHES, ERIC A | Director | Buy | 44,200 | — | — |
| 2024-10-29 | VERSANT, VENTURE CAPITAL VI, L.P. | 10% Owner | Sale | 52,305 | $9.08 | $475007.86 |
Frequently asked questions
Are GLUE insiders buying or selling?
Over the transactions on record, GLUE insiders have been net buyers, with about $3.46M in stock sold across 47 sales, against 12 open-market purchases.
Does insider selling at GLUE mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which GLUE insiders are selling the most?
Recent selling is concentrated in a few names. JANKU, FILIP accounts for the largest share on record, with about $1.25M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.